酸和酸对Helicobacter pylori尿解的抑制活性
Marta Maślanka1, Wojciech Tabor1, Paweł Krzyżek2
1Department of Bioorganic Chemistry, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370, Wrocław, Poland.
European journal of medicinal chemistry
|June 8, 2023
概括
新的教理性化合物被合成,以抑制尿酶酶. 最有效的衍生品对Helicobacter pylori表现出显著的抗尿酶和抗尿解活性,没有观察到细胞毒性.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 酶抑制可以抑制酶.
背景情况:
- 卡特科尔是已知的尿酶酶的共价抑制剂.
- 抑制通过修改酶的活性部位的氨酸残留物来发生.
研究的目的:
- 设计和合成具有增强特异性相互作用的新型教化衍生物.
- 评估这些化合物的抗尿酶和抗尿溶性潜力.
主要方法:
- 合成含有碳酸盐和/蛋白功能的新型白内素衍生物.
- 在甲醇和水中进行化学稳定性研究.
- 在体外用Sporosarcinia pasteurii尿酶进行尿酶抑制试验.
- 在Helicobacter pylori细胞中的体内抗尿解活性评估.
- 分子建模以阐明结合相互作用.
主要成果:
- 化合物2-(3,4-二基) -3-素酸 (15) 显示出强大的尿酶抑制 (Ki = 2.36 μM).
- 化合物15在Helicobacter pylori中表现出显著的抗尿解活性 (IC50 = 0.75μM).
- 分子建模揭示了在尿酶活性部位内的特定静电和键相互作用.
结论:
- 新型教化酸酸是有效的尿酶抑制剂.
- 化合物15在治疗Helicobacter pylori感染方面表现有前途,因为它具有强大的抗尿解活性.
- 这些化合物具有化学稳定性,对真核细胞无细胞毒性,并表现出特定的抗尿素分解活性.
相关概念视频
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
475
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
475
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
523
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
523
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
467
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
467
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
650
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
650
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
407
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
407
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
472
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
472